Markets:

Overview

News

Currencies

International

Treasuries

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

1.240 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Revelation Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 08, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

March 17, 2025

Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 17, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Monday's session. ↗

March 17, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Which stocks are moving before the opening bell on Monday? ↗

March 17, 2025

The US market session of Monday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 17, 2025

Via Benzinga

Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

March 17, 2025

Via Benzinga

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

March 17, 2025

From Revelation Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 14, 2025

Via Benzinga

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

March 13, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

March 06, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

February 26, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

February 24, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session. ↗

January 28, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Via Chartmill

These stocks are moving in today's session ↗

January 28, 2025

Curious to know what's happening on the US markets in the middle of the day on Tuesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

The market is filled with gapping stocks in Tuesday's session. ↗

January 28, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

January 24, 2025

From Revelation Biosciences Inc.

Via Business Wire

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

January 21, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

January 13, 2025

From Revelation Biosciences, Inc.

Via Business Wire

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

January 06, 2025

From Revelation Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 03, 2024

Via Benzinga

Why Revelation Biosciences (REVB) Stock Is Down 38% ↗

December 03, 2024

Revelation Biosciences shares are trading lower by 38% during Tuesday's session. The company agreed to a $4M warrant exercise, closing December 3.

Via Benzinga

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

December 03, 2024

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

December 02, 2024

From Revelation Biosciences, Inc.

Via Business Wire

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

November 12, 2024

From Revelation Biosciences, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 11, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.